Questions parents actually ask.
Straight answers, with selected scientific and regulatory references supporting our formulation approach.
Everything you wanted to know, honestly answered.
If your question isn’t here, write to us at hello@tenderma-india.com — a real person reads every email.
Why a new brand when there are already so many baby skincare options?
Tenderma did not begin with the idea of making another gentle baby range. It began with a narrower question: what would change if Indian heat, humidity, mineral-heavy water and everyday care routines were written into the formulation specification from the beginning, rather than considered afterwards?
The answer shaped the textures, the cleansing system, the botanical specifications and the routine guidance. We also wanted parents to be able to see why each ingredient was chosen, what evidence sits behind it, and where the evidence comes from.
What does “dermatology-led” actually mean here?
It means the formulation is written as a specification before any sample is made, and that specification is built on published clinical evidence — ingredient choices, concentrations, pH and exclusions — rather than on what is trending or what reads well on a label. Every deviation our manufacturer proposes has to come back to us for sign-off.
“Dermatology-led” describes how we formulate and review, not a clinical endorsement of any individual product. It is not a regulated term, and it does not mean a dermatologist has examined your baby.
It also means we don’t add ingredients just to make a marketing claim. If something isn’t doing real work for your baby’s skin, it doesn’t go in.
How can you be both “science-led” and “Ayurveda-enriched”? Aren’t those contradictory?
Not when done properly. Many traditional Ayurvedic ingredients — like neem, turmeric, and aloe vera — have well-documented active compounds with measurable skincare benefits. The problem with most Ayurvedic baby products is that the actives aren’t standardized, so potency varies batch to batch, and dosage isn’t controlled.
We use Ayurvedic ingredients in their standardized extract form — meaning the active compound is measured and consistent in every bottle — at concentrations validated for safety on infant skin. It’s the heritage benefit with modern formulation discipline.
From what age can I use Tenderma on my baby?
Developed for babies and children — the wash, lotion and soothing cream for 0–12 years, the massage oil for 0–5, the rash cream for 0–3. If your baby was premature, or has a diagnosed skin condition, speak with your paediatrician before introducing any new product.
My baby has eczema or very sensitive skin. Are these safe?
Eczema and atopic dermatitis are medical conditions. Tenderma products are cosmetics and are not intended to diagnose or treat them.
If your baby has diagnosed eczema, persistent redness, broken or weeping skin, or recurring flare-ups, speak with your paediatrician before introducing a new product. Where a doctor is happy for you to continue ordinary skincare, our formulations are sulfate-free, made without synthetic perfume and pH-balanced for infant skin. Four products contain named botanical scent materials; the Rash Protection Cream contains none, and we would still suggest patch testing a small area for 48 hours first.
How do I patch test a new product?
Apply a small amount — about the size of a pea — to the inside of your baby’s forearm. Leave it for 24 to 48 hours and watch for redness, itching, swelling, or any reaction. If skin stays calm, the product is generally safe for broader use.
If you notice any reaction, wash the area with plain water, stop use immediately, and consult your paediatrician if symptoms persist.
What does “formulated for Indian climate” actually mean?
Three specific things:
1. Heat & humidity tolerance. Our emulsions are specified to stay stable up to 45°C without separating, and accelerated stability testing at our manufacturer has passed.
2. Hard water compatibility. Water hardness varies by source and location, and where the tap runs hard, many cleansers leave residue, irritate skin, and dry out the barrier. Our wash is formulated to rinse cleanly even in hard water.
3. The conditions, not the biology. A baby’s skin follows the same fundamental biology everywhere. What differs is what it goes through — heat, humidity, water hardness, pollution and daily routine. Our ingredient ratios, pH and emollient choices are built around those conditions rather than around any claim of different skin.
What do you use for fragrance?
No synthetic perfume, in any product. Where a product is scented, we use a named botanical and we tell you which one, at the level it appears in the ingredient list.
Wash — sandalwood oil and German chamomile extract. Lotion and Soothing Cream — Roman chamomile flower oil. Massage Oil — vetiver root oil, the traditional khus. Rash Protection Cream — nothing at all. The nappy area is the one place where we would rather have no scent than a pleasant one.
We are not going to tell you botanical scent is risk-free. Chamomile belongs to the same plant family as calendula and ragweed, and a small number of babies react to it. That is why the ingredient list names the species rather than hiding it behind the word “fragrance”, and why we ask you to patch test.
Are your products vegan and cruelty-free?
Yes to both. No animal-derived ingredients, no animal testing — not by us, and not by any of our suppliers. We’ll publish full certifications at launch.
Where are the products made?
Manufactured in India at GMP-certified facilities, formulated with ingredients sourced from validated suppliers globally. We’ll publish detailed ingredient sourcing and manufacturing certifications on each product page at launch — full transparency, no exceptions.
When are you launching, and where can I buy?
We’re launching December 2026, starting direct-to-consumer through tenderma-india.com. Amazon and Flipkart follow in Q1 2028. We are not planning to list on quick commerce. Waitlist members get first access, well before any marketplace.
What happens after I join the waitlist?
You’ll get a confirmation email immediately. As we approach launch, you’ll receive periodic updates on formulation milestones, ingredient deep-dives, and cohort timing. The December launch is public and open to everyone; joining the cohort is about trying the products early and telling us what you think.
No spam. Unsubscribe anytime. Your email never gets sold or shared.
Still have questions? We answer every email personally.
Email Us →Every figure we quote has a source.
These are the sources behind the specific figures we quote. Where a claim rests on supplier data rather than published research, we say so alongside the ingredient.
Menon S, Bhatia A. Exploring Atopic Dermatitis in Indian Children: A Comprehensive Survey. Cureus 2025;17(7).
Nationwide survey of 1,003 Indian parents — 17.85% reported atopic dermatitis in children under 5. Cited for the easily-irritated figure on the Science page.
pmc.ncbi.nlm.nih.gov ↗Salvi AN et al. Clinical effects of diaper on Indian babies with diaper rash. IP Indian J Clin Exp Dermatol, 2022.
India-specific clinical study — 4–35% diaper dermatitis incidence in children up to 2 years. Cited for the nappy-area figure on the Science page.
ijced.org ↗Gopinath H et al. A cross-sectional study of sweat-induced dermatitis during a South Indian summer. Int J Dermatol, 2019;58(1):86–90.
Hospital study — miliaria rubra was the dominant sweat-induced condition (84.1%). Cited for the prickly heat card on the Science page.
pubmed.ncbi.nlm.nih.gov ↗Bureau of Indian Standards. IS 10500:2012 — Drinking Water Specification.
Sets 500 mg/L as the acceptable limit for total dissolved solids and 2,000 mg/L as the permissible limit where no alternative source is available; hardness is the calcium and magnesium share of that load. Cited for the hardness definition on the hard-water card on the Science page.
bis.gov.in ↗Stamatas GN et al. Infant skin physiology and development during the first years of life. Int J Cosmetic Sci, 2011;33(1):17–24.
Trans-epidermal water loss and moisture dynamics differ between infant and adult skin. Cited for the moisture-loss line on the Science page. Not Indian research — included because the physiology is not country-specific.
pubmed.ncbi.nlm.nih.gov ↗The evidence behind what is in the bottle.
Our products are for children from newborn to twelve. Several of the ingredients are ones parents mostly meet in adult skincare, and the reasonable question is what they are doing in a baby product. This is the answer, ingredient by ingredient — including the places where the evidence is thinner than we would like.
A note on how this list is written: every entry links to the record itself. Where we could not confirm a volume or page number against a bibliographic record, we have left it out rather than fill it in. Nothing here is a claim about our finished products — these are papers about ingredients and about skin.
Almost every decision below rests on one fact: a child's skin is not small adult skin, and it is still maturing long after the first birthday. That is why three of our five products carry on to twelve.
| Paper | What it tells us | Source |
|---|---|---|
| Stamatas GN, et al. 2011. Infant skin physiology and development during the first years of life: a review of recent findings based on in vivo studies. International Journal of Cosmetic Science. | Infant skin has a thinner stratum corneum, higher water loss and different hydration dynamics from adult skin, and the barrier is still maturing through the first years. This is the paper behind our “not small adult skin” position. | pubmed.ncbi.nlm.nih.gov ↗ |
| Stamatas GN, et al. 2023. Skin maturation from birth to 10 years of age: structure, function, composition and microbiome. Experimental Dermatology. | Maturation continues well past infancy, to roughly ten years. This is the direct answer to “why does a baby brand go to twelve?” | onlinelibrary.wiley.com ↗ |
| 2025. Skin barrier function in neonates and infants. Allergy, Asthma & Immunology Research 17(1). | A current review of neonatal and infant barrier function, water loss and surface pH. | pubmed.ncbi.nlm.nih.gov ↗ |
| 2000. Direct comparison of skin physiology in children and adults with bioengineering methods. | Instrumented comparison of children’s and adults’ skin — the evidence for the toddler-to-twelve span rather than infancy alone. | pubmed.ncbi.nlm.nih.gov ↗ |
| 2000. Skin barrier properties in different body areas in neonates. | Barrier properties differ by body site in newborns. Why the nappy-area product is formulated differently from the face-and-body ones. | pubmed.ncbi.nlm.nih.gov ↗ |
Niacinamide is usually met in adult products, and the assumption follows that it is an adult ingredient. It is not: it is a vitamin B3 derivative whose main action in skin is to make the barrier’s own lipids. What we can say honestly is set out here, including what the evidence does not cover.
| Paper | What it tells us | Source |
|---|---|---|
| Tanno O, Ota Y, Kitamura N, Katsube T, Inoue S. 2000. Nicotinamide increases biosynthesis of ceramides as well as other stratum corneum lipids to improve the epidermal permeability barrier. British Journal of Dermatology 143(3):524–531. | Topical nicotinamide increased ceramide, free fatty acid and cholesterol synthesis and improved permeability barrier function. This is the mechanism — niacinamide helps skin build its own barrier lipids, which is exactly what an immature barrier is short of. | pubmed.ncbi.nlm.nih.gov ↗ |
| Cosmetic Ingredient Review Expert Panel 2005. Final report of the safety assessment of niacinamide and niacin. International Journal of Toxicology 24(Suppl 5):1–31. | The formal cosmetic safety assessment concluding niacinamide is safe as used. This is a safety position, not an efficacy claim. | pubmed.ncbi.nlm.nih.gov ↗ |
| Rolfe HM. 2014. A review of nicotinamide: treatment of skin diseases and potential side effects. Journal of Cosmetic Dermatology 13(4):324–328. | Reviews nicotinamide’s dermatological uses and its side-effect profile. Supports the low-irritancy position. | pubmed.ncbi.nlm.nih.gov ↗ |
| Soma Y, et al. 2005. Moisturizing effects of topical nicotinamide on atopic dry skin. International Journal of Dermatology. | Improved hydration and reduced water loss in atopic dry skin. Adult study — we are not presenting it as paediatric evidence. | pubmed.ncbi.nlm.nih.gov ↗ |
| Bains P, Kaur M, et al. Nicotinamide: mechanism of action and indications in dermatology. Indian Journal of Dermatology, Venereology and Leprology. | An Indian peer-reviewed review of the same mechanism and its dermatological indications. | pubmed.ncbi.nlm.nih.gov ↗ |
| Paper | What it tells us | Source |
|---|---|---|
| McClanahan D, Wong A, et al. 2019. A randomized controlled trial of an emollient with ceramide and filaggrin-associated amino acids for the primary prevention of atopic dermatitis in high-risk infants. | A ceramide-containing emollient used from early infancy in infants at high risk of atopic dermatitis. | pubmed.ncbi.nlm.nih.gov ↗ |
| Zhong Y, et al. 2022. Emollients in infancy to prevent atopic dermatitis: a systematic review and meta-analysis. Allergy. | The pooled position on emollient use in infancy, rather than any single trial. | pubmed.ncbi.nlm.nih.gov ↗ |
| Chalmers JR, et al. 2020. Daily emollient during infancy for prevention of eczema: the BEEP randomised controlled trial. The Lancet. | A large trial that did not find daily emollient from birth prevented eczema. We list it because a reference page that cites only the favourable results is not a source of truth. | pubmed.ncbi.nlm.nih.gov ↗ |
| 2018. Emollient use alters skin barrier and microbes in infants at risk for developing atopic dermatitis. | Regular emollient use measurably changes both barrier parameters and the skin’s microbial communities in at-risk infants. | pubmed.ncbi.nlm.nih.gov ↗ |
| Paper | What it tells us | Source |
|---|---|---|
| Proksch E, et al. 2017. Topical use of dexpanthenol: a 70th anniversary article. Journal of Dermatological Treatment. | The standard review of dexpanthenol’s mechanism — hydration, barrier support, and behaviour on irritated skin. | pubmed.ncbi.nlm.nih.gov ↗ |
| Peltier E, et al. 2023. Evaluation of a 5% dexpanthenol-containing ointment for the treatment of infant irritant diaper dermatitis through the lens of the caregiver — a real-world data observational study. Health Science Reports. | Dexpanthenol specifically in the infant nappy area, in ordinary use rather than trial conditions. | pubmed.ncbi.nlm.nih.gov ↗ |
| Wananukul S, et al. 2006. Comparison of dexpanthenol and zinc oxide ointment with ointment base in the treatment of irritant diaper dermatitis from diarrhea: a multicenter study. | Head-to-head clinical use of dexpanthenol and zinc oxide in infant irritant nappy dermatitis. | pubmed.ncbi.nlm.nih.gov ↗ |
| Paper | What it tells us | Source |
|---|---|---|
| Fluhr JW, et al. 2008. Glycerol and the skin: holistic approach to its origin and functions. British Journal of Dermatology 159(1). | Glycerol’s origin in skin, its humectant function, and its role in hydration and barrier repair. | pubmed.ncbi.nlm.nih.gov ↗ |
| 2007. Placebo-controlled, double-blind, randomized, prospective study of a glycerol-based emollient on eczematous skin in atopic dermatitis. | Clinical benefit of a glycerol-based emollient on eczematous skin. | pubmed.ncbi.nlm.nih.gov ↗ |
| 2009. Electrometric assessment of the effect of a zinc oxide paste in diaper dermatitis. | Instrumented rather than visual assessment of a zinc oxide paste in nappy dermatitis. | pubmed.ncbi.nlm.nih.gov ↗ |
| Paper | What it tells us | Source |
|---|---|---|
| Lisante TA, et al. 2017. Efficacy and safety of an over-the-counter 1% colloidal oatmeal cream in the management of mild to moderate atopic dermatitis in children: a double-blind, randomized, active-controlled study. Journal of Dermatological Treatment. | Colloidal oatmeal tested in children rather than adults. The strongest paediatric citation in this group. | www.tandfonline.com ↗ |
| Cerio R, Dohil M, et al. 2010. Mechanism of action and clinical benefits of colloidal oatmeal for dermatologic practice. Journal of Drugs in Dermatology. | The anti-inflammatory and anti-itch mechanisms behind colloidal oatmeal. | pubmed.ncbi.nlm.nih.gov ↗ |
| Araújo LU, et al. 2010. Profile of wound healing process induced by allantoin. | Allantoin’s effect on tissue repair. An experimental model, not paediatric skin. The allantoin literature is genuinely thin, and we would rather say so than dress it up. | pubmed.ncbi.nlm.nih.gov ↗ |
These are the two ingredients most people have never heard of. They are in the formulation because a daily bath in mineral-heavy water is an osmotic stress on skin, not just a cleansing one.
| Paper | What it tells us | Source |
|---|---|---|
| Warskulat U, et al. 2006. Taurine improves epidermal barrier properties stressed by surfactants — a role for osmolytes in barrier homeostasis. | Taurine protects the epidermal barrier against surfactant stress. Directly relevant to pairing an osmolyte with a cleanser. | pubmed.ncbi.nlm.nih.gov ↗ |
| Janeke G, et al. 2003. Role of taurine accumulation in keratinocyte hydration. | How taurine accumulation works as a hydration and osmoregulation mechanism in skin cells. | pubmed.ncbi.nlm.nih.gov ↗ |
| 2020. Organic osmolytes increase expression of specific tight junction proteins in skin and alter barrier function in keratinocytes. | Osmolytes as a class — which includes betaine and taurine — influencing tight-junction proteins and barrier function. | pubmed.ncbi.nlm.nih.gov ↗ |
| Paper | What it tells us | Source |
|---|---|---|
| Kennedy EA, et al. 2017. Skin microbiome before development of atopic dermatitis: early colonization with commensal staphylococci at 2 months is associated with a lower risk of atopic dermatitis at 1 year. | Early microbial colonisation patterns on infant skin, and their association with later atopic dermatitis risk. | pubmed.ncbi.nlm.nih.gov ↗ |
| 2022. A randomized clinical study on the effects of emollient use on the developing infant skin microbiome and metabolome. | How routine emollient use interacts with the developing infant microbiome — the infant-specific evidence in this group. | pubmed.ncbi.nlm.nih.gov ↗ |
| 2023. Effects of a lotion containing probiotic ferment lysate as the main functional ingredient on enhancing skin barrier: a randomized, self-control study. | A topical ferment lysate improving barrier measures. Adult study — there is no infant data for ferment lysate that we could find. | pubmed.ncbi.nlm.nih.gov ↗ |
| Paper | What it tells us | Source |
|---|---|---|
| Blume-Peytavi U, et al. 2012. Skin care practices for newborns and infants: review of the clinical evidence for best practices. Pediatric Dermatology. | The guideline-grade consensus on newborn and infant cleansing and emollient use. | pubmed.ncbi.nlm.nih.gov ↗ |
| Lavender T, et al. 2011. Infant skin-cleansing product versus water: a pilot randomized, assessor-blinded controlled trial. BMC Pediatrics 11:35. | A well-formulated infant wash was not inferior to plain water on barrier measures. The direct answer to “just use water”. | pubmed.ncbi.nlm.nih.gov ↗ |
| 2013. Randomized, controlled trial evaluating a baby wash product on skin barrier function in healthy, term neonates. | Trial evidence on a baby wash and neonatal barrier function. | pubmed.ncbi.nlm.nih.gov ↗ |
This is the condition that shaped our cleansing system more than any other. The Indian figure is a standards figure; the skin evidence is international, because we could not find an Indian dermatological dataset on it.
| Paper | What it tells us | Source |
|---|---|---|
| Jabbar-Lopez ZK, Ung CY, et al. 2021. The effect of water hardness on atopic eczema, skin barrier function: a systematic review, meta-analysis. Clinical & Experimental Allergy. | Pooled evidence linking domestic water hardness to atopic eczema and impaired barrier function. | pubmed.ncbi.nlm.nih.gov ↗ |
| McNally NJ, et al. 1998. Atopic eczema and domestic water hardness. The Lancet. | The original epidemiological association between water hardness and childhood eczema. | pubmed.ncbi.nlm.nih.gov ↗ |
| 2015. Water hardness and eczema at 1 and 4 y of age in the INMA birth cohort. | Birth-cohort data on water hardness and eczema at ages one and four. | pubmed.ncbi.nlm.nih.gov ↗ |
| Paper | What it tells us | Source |
|---|---|---|
| Skin care practices in Indian newborns and infants: current scenario. | Indian-specific infant skincare practice patterns — what families here actually do, which is what a routine has to fit around. | pmc.ncbi.nlm.nih.gov ↗ |
| Pediatric dermatoses in India. Indian Journal of Dermatology, Venereology and Leprology. | Prevalence patterns for childhood skin conditions in India. | ijdvl.com ↗ |
All references accessed August 2026. If you think we have read one wrongly, write to care@tenderma-india.com — we would rather correct it than defend it.
Still unsure about something? Write to care@tenderma-india.com and a founder will answer — not a template.